Covid
A nice US based compassionate use study posted on the YMB, with a ventilator patient recovering almost completely, in four weeks. Said patient went back to work in the pharma industry, instead of heading to the morgue. The thought occurs, roughly 4-5% of all vaccinated patients fail to develop antibodies, as is the case for a member of the New York Yankees baseball management. It sure looks like there will be an ongoing need for narso treatment, although pricing remains a conundrum. However, if you have 5 or 6k ventilator patients every year, US & Europe, that could be a nice add on market. Lingering after effects like ED ? Priceless.